Blood-based surveillance after surgery increased curative treatment for recurrence

▪ SCREENING

The phase III FIND trial showed that ctDNA methylation-guided surveillance in nonmetastatic colorectal cancer patients after surgery led to higher rates of curative-intent therapy for recurrence compared to standard CT-based monitoring. (Journal of Clinical Oncology)